Page last updated: 2024-10-24

B cell homeostatic proliferation

Definition

Target type: biologicalprocess

The non-specific expansion of B cell populations within a whole or part of an organism to reach to a total number of B cells which will then remain stable over time in the absence of an external stimulus. [GOC:jal]

B cell homeostatic proliferation is a tightly regulated process that ensures a stable population of mature B cells in the absence of overt antigenic stimulation. It involves a delicate balance of survival, proliferation, and differentiation signals, ensuring a constant pool of B cells capable of responding to pathogens. This process takes place primarily within the bone marrow and the spleen, and relies on several key factors:

* **Survival Signals:** B cells constantly receive survival signals from their microenvironment. These signals, often provided by stromal cells in the bone marrow or follicular dendritic cells in the spleen, engage receptors like BAFF (B cell activating factor) and APRIL (A proliferation-inducing ligand). These interactions activate signaling pathways that promote B cell survival, preventing apoptosis.

* **Intrinsic Factors:** B cells themselves possess intrinsic mechanisms that contribute to their homeostatic proliferation. The transcription factor Pax5, a key regulator of B cell development, also influences homeostatic proliferation. Additionally, certain genes involved in cell cycle regulation, like c-Myc and Cyclin D2, are expressed at low levels in resting B cells, ready to be upregulated upon appropriate stimulation.

* **T-Cell Independent Signals:** While B cell development primarily depends on T cell-dependent signals for activation and differentiation, homeostatic proliferation is largely T-cell independent. Instead, it can be triggered by weak or repetitive exposure to self-antigens, known as "tonic signaling." These signals, often delivered by self-antigens presented on follicular dendritic cells, are not strong enough to induce full B cell activation but provide a low-level stimulation that promotes survival and modest proliferation.

* **Regulation of Homeostatic Proliferation:** The process of homeostatic proliferation is not uncontrolled. Several factors help regulate it, preventing excessive B cell expansion. These include:
* **Negative feedback loops:** As B cell numbers increase, they can trigger negative feedback mechanisms that suppress further proliferation, ensuring a balanced population.
* **Apoptosis:** B cells that fail to receive appropriate survival signals or are defective in their development undergo programmed cell death (apoptosis), further contributing to the regulation of B cell numbers.

In essence, B cell homeostatic proliferation is a dynamic process that ensures a steady supply of mature B cells. This process relies on a combination of survival signals, intrinsic factors, and low-level stimulation, all tightly regulated to prevent excessive B cell expansion and maintain a healthy immune system.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Apoptosis regulator BAX An apoptosis regulator BAX that is encoded in the genome of human. [PRO:SY, UniProtKB:Q07812]Homo sapiens (human)

Compounds (2)

CompoundDefinitionClassesRoles
vorinostatvorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
dicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor